strength, quality of life, depression, fear fatigue, and pain all improved following the exercise intervention. Conclusion: Exercise is an effective means to manage treatment-related symptoms in cancer and should be a part of the standard of care.
Search Results
Karen Wonders, Rob Wise, and Danielle Ondreka
Murali Sundaram, Kathleen L. Deering, Dolly Sharma, Qing Harshaw, Jeremiah Trudeau, and Jacqueline C. Barrientos
. Respondents completed demographic/clinical information and surveys via phone (Functional Assessment of Cancer Therapy-General [FACT-G], FACT-Leukemia, and Functional Assessment of Chronic Illness Therapy [FACIT]-Fatigue and Cancer Therapy Satisfaction
Karen Hock and Cari Utendorf
fibrosis and fatigue. Results: The data will demonstrate an increase in percentage of pre-operative assessments since the implementation of this program in January 2018. In addition, the data will demonstrate the increased opportunity to treat subclinical
John Mascarenhas, Arianna Kee, Hiep Nguyen, Ashley Saunders, Louisa Oliver, Hannah Tomkinson, Richard Perry, and Ali McBride
consensus statements suggest patient-reported symptoms of fatigue, poor concentration, inactivity, and bone pain were too general to define RUX failure compared with other specific MF symptoms ie, night sweats. Following RUX failure, consensus
Pam Baker DeGuzman, Veronica Bernacchi, C. Allen Cupp, B. J. Ferrebee Ghamandi, Ivora D. Hinton, Mark J. Jameson, Debra Lynn Lewandowski, and Christi Sheffield
16 participants, the most common issues identified were fatigue (69%), worry (63%), family health issues (56%) and hearing loss (56%). Although only 3 participants identified jaw swelling as an issue, this was the most highly rated area of distress on
Vishal Kapadia, Elisa Griswold, Kelley Newcomer, Brittny Tillman, Jane Mwangi, and Stephanie Terauchi
diagnosis. Pain was the most distressing symptom, where 13/21 patients had severe pain with an average modified ESAS score of 6. Fatigue, odynophagia, sense of wellbeing, and dysphagia were amongst the other symptoms with average modified ESAS scores of ≥4
Sonali Agrawal, Caitlin R. Meeker, Sandeep Aggarwal, Elizabeth A. Handorf, Sunil Adige, Efrat Dotan, Crystal S. Denlinger, William H. Ward, Jeffrey M. Farma, and Namrata Vijayvergia
(others were on clinical trials with novel agents). Most common grade 3+ tox reported by providers included nausea (10%) and neuropathy (8%), while the common clinically significant tox reported by pts were neuropathy (20%), fatigue (20%), and anxiety (15
Chao-Hui Sylvia Huang, Jennifer K. Anderson, Jasmine A. Boykin, Jasmine K. Vickers, Heather Forbes, Kellie L. Flood, Lisle M. Nabell, and Kelly N. Godby
strategies to manage anxiety or depression. Barriers to receive counseling services include physical symptom burden such as pain and fatigue, medical procedures, and inadequate psychosocial care staffing. Findings revealed high perceived needs and patient
Ping Jiang, Ang Qu, Weijuan Jiang, Xiuwen Deng, and Junjie Wang
twice a week. Dose escalation followed a 3 + 3 design. The DLT was defined as grade 3 or 4 nonhematologic toxicity, excluding nausea, vomiting and alopecia, decreased appetite and fatigue, or grade 4 hematologic toxicity. Results : This study was
Brian Seal, Candice Yong, M. Janelle Cambron-Mellott, Oliver Will, Martine C. Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla, and Ranee Mehra
%, and all G neuropathy from 5% to 39%, if OS increased by 17, 4, and 2 months, respectively. In addition, pts would require an increase in OS of 1 month to accept an increase in G3/4 fatigue from 1% to 12% or all G pneumonitis from <1% to 8%. Preferences
